New research has backed the potential of artificial intelligence (AI) as a diagnostic tool, but warned that the patchy nature of available literature may have led to exaggerated claims abou
Pfizer and Catalia Health have launched a year-long pilot scheme exploring how patients engage with cute robot companions that use artificial intelligence (AI) to check on symptom managemen
Atomwise and Hansoh Pharma have announced an artificial intelligence (AI) drug discovery deal that could be worth $1.5 billion, the largest US-China collaboration in the field.